Results for "Stem Cell Banking"

20 articles

Banked Bone Marrow Could Rebuild Aging Immune Systems at Scale
Longevity & Aging

Banked Bone Marrow Could Rebuild Aging Immune Systems at Scale

Ossium Health is banking donor bone marrow for on-demand transplant, targeting immune aging as a future healthspan intervention.

Press Release
May 20, 2026 0
China Launches 2000-Person Stem Cell Trial to Combat Age-Related Decline
Longevity & Aging

China Launches 2000-Person Stem Cell Trial to Combat Age-Related Decline

Beijing's 301 Hospital begins recruiting adults 50+ for the world's largest stem cell antiaging clinical trial using an already-approved therapy.

Press Release
Jun 12, 2026 0
Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them
Longevity & Aging

Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them

A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace โ€” not just repair โ€” aging biology.

Press Release
May 1, 2026 0
Scientists Turn One Stem Cell Into 14 Million Cancer-Fighting NK Cells
Cancer Research

Scientists Turn One Stem Cell Into 14 Million Cancer-Fighting NK Cells

Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.

Press Release
Mar 29, 2026 0
Heartseed Begins Stem Cell Trial to Repair Failing Hearts in DCM Patients
Longevity & Aging

Heartseed Begins Stem Cell Trial to Repair Failing Hearts in DCM Patients

Heartseed's iPSC-derived heart cell therapy enters Phase I/II trial for dilated cardiomyopathy, with first patient data cleared by safety board.

Press Release
Jun 13, 2026 0
Lab-Grown Blood Cells Match Donor Survival Time in Landmark Biotech Result
Longevity & Aging

Lab-Grown Blood Cells Match Donor Survival Time in Landmark Biotech Result

Scarlet Therapeutics grows universal red blood cells that survive as long as donated ones, opening a path to engineered therapeutic blood.

Press Release
May 12, 2026 0
FDA Fast-Tracks Direct-to-Brain Stem Cell Therapy Targeting Alzheimer's Disease
Longevity & Aging

FDA Fast-Tracks Direct-to-Brain Stem Cell Therapy Targeting Alzheimer's Disease

RBI's Wnt-activated stem cells injected directly into the brain show early promise reducing tau and amyloid markers in Phase 1.

Press Release
Jun 17, 2026 0
Muse Cells May Outperform Traditional Stem Cell Therapies for Aging and Repair
Longevity & Aging

Muse Cells May Outperform Traditional Stem Cell Therapies for Aging and Repair

A rare stress-enduring stem cell subpopulation called Muse cells could solve regenerative medicine's biggest failures and slow tissue aging.

Press Release
Jun 16, 2026 0
Biotech Firms Race to Treat Aging Itself Using Living Cell Therapies
Longevity & Aging

Biotech Firms Race to Treat Aging Itself Using Living Cell Therapies

A new wave of biotechs is targeting aging as a root cause, using encapsulated cells and gene therapy to restore lost proteins and reverse decline.

Press Release
Apr 18, 2026 0
Parkinson's Patients Regain Movement After Brain Repair Using Their Own Cells
Longevity & Aging

Parkinson's Patients Regain Movement After Brain Repair Using Their Own Cells

Aspen Neuroscience's stem cell therapy restored dopamine neurons in Parkinson's patients, adding ~2 hours of controlled movement daily.

Press Release
May 5, 2026 0
Engineered Stem Cells Become Lifelong Antibody Factories Against HIV and Flu
Longevity & Aging

Engineered Stem Cells Become Lifelong Antibody Factories Against HIV and Flu

Rockefeller scientists reprogrammed blood stem cells to produce rare broadly neutralizing antibodies, offering a potential one-time immunity platform.

Press Release
Apr 18, 2026 0
How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists
Regenerative Medicine

How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists

Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.

Press Release
May 28, 2026 0
Cellbricks Therapeutics Raises โ‚ฌ10M to Advance Biofabricated Tissue Implants
Longevity & Aging

Cellbricks Therapeutics Raises โ‚ฌ10M to Advance Biofabricated Tissue Implants

Biotech company secures funding to move lab-grown human tissue implants toward clinical trials, starting with adipose tissue.

Press Release
Mar 30, 2026 0
Why Most Stem Cells Never Reach Their Target and What Could Fix That
Longevity & Aging

Why Most Stem Cells Never Reach Their Target and What Could Fix That

A rare stress-resilient cell type may solve the biggest failure in stem cell therapy: most injected cells never reach damaged tissue.

Press Release
Jun 20, 2026 0
Stem Cell and Senolytic Combo Extends Mouse Lifespan by Over 70%
Longevity & Aging

Stem Cell and Senolytic Combo Extends Mouse Lifespan by Over 70%

A dual therapy clearing senescent cells and restoring stem cell function dramatically extended mouse lifespan in a new preclinical study.

Press Release
Jun 18, 2026 0
Astellas Stem Cell Eye Therapy Shows Early Promise for Age-Related Vision Loss
Regenerative Medicine

Astellas Stem Cell Eye Therapy Shows Early Promise for Age-Related Vision Loss

Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.

Press Release
May 11, 2026 0
Automated Cell Therapy Factories Just Delivered Real Patient Doses on Schedule
Longevity & Aging

Automated Cell Therapy Factories Just Delivered Real Patient Doses on Schedule

Cellares raises $277M to scale robotic CAR T manufacturing after delivering first GMP-grade doses to patients, signaling a shift from science to supply.

Press Release
Jun 15, 2026 0
CD34+ Stem Cell Therapy Heads to Phase 3 to Repair Hearts After Heart Attack
Longevity & Aging

CD34+ Stem Cell Therapy Heads to Phase 3 to Repair Hearts After Heart Attack

CellProthera's ProtheraCytes targets heart repair post-myocardial infarction, aiming to prevent heart failure before damage becomes irreversible.

Press Release
Jun 3, 2026 0
Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics
Longevity & Aging

Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics

Sana Biotechnology and Mayo Clinic are advancing SC451, a cell therapy that may restore natural insulin production without immunosuppression.

Press Release
May 1, 2026 0
XellSmart Launches Phase II Trial of iPSC Therapy for Parkinson's Disease
Longevity & Aging

XellSmart Launches Phase II Trial of iPSC Therapy for Parkinson's Disease

Chinese biotech begins multicenter trial of stem cell therapy showing promising early results for Parkinson's motor symptoms and quality of life.

Press Release
Apr 17, 2026 0
Page 1 of 2Next